News on the Division of Intramural Research
|
Statement
Statement from Gary H. Gibbons, M.D., Director of NHLBI: I take great pleasure in announcing that Rear Admiral Richard Childs, M.D. , has accepted the position of Scientific Director (SD) of the Division of Intramural Research (DIR), effective February 7, 2024. Childs has served as NHLBI Clinical Director since 2013 and Acting Scientific Director...
|
Media Availability
WHAT: A scientist from the National Institutes of Health will present promising, early results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease. Preliminary findings suggest that the approach has an acceptable level of safety and might help patients consistently produce normal red blood...